ArticleClinical ophthalmology (Auckland, N.Z.)2020

Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma.

Patrick Martin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.